
Chairwoman Maloney's Opening Statement: Unsustainable Drug Prices (Part III)
9 Video Views·Jan 30, 2023
Committee on Oversight and Reform Chairwoman Carolyn B. Maloney’s opening statement, as prepared for delivery, during today’s full committee hearing examining the pricing and business practices of AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica.
